美国 · 股市与财经 · Yahoo Finance

AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)

来源：Yahoo Finance · 美国 8 小时前

AnnJi Pharmaceutical Co., Ltd. (AnnJi, TPEx: 7754), a clinical-stage drug development company focused on innovative small molecules, today announced that it is proceeding with the…

在 Yahoo Finance 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)

推荐阅读

Japan’s PMI data signals cooling momentum across manufacturing and services

Joint venture of OKX and NYSE parent ICE files for 24/7 tokenized U.S. stock trading

Russia hospitalizes almost 200 people after researcher's death from plague: reports

After 11 years on an H-1B visa, I still miss my family back home. Here’s why I stay in the US.

Zcash activates NU7 on testnet ahead of November mainnet target

Sam Altman says 'the world should accept some bad things happening for the benefits' of AI

AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)

分享

推荐阅读

Japan’s PMI data signals cooling momentum across manufacturing and services

Joint venture of OKX and NYSE parent ICE files for 24/7 tokenized U.S. stock trading

Russia hospitalizes almost 200 people after researcher's death from plague: reports

After 11 years on an H-1B visa, I still miss my family back home. Here’s why I stay in the US.

Zcash activates NU7 on testnet ahead of November mainnet target

Sam Altman says 'the world should accept some bad things happening for the benefits' of AI